Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
110M
-
Shares change
-
+624K
-
Total reported value, excl. options
-
$3.59B
-
Value change
-
+$35.4M
-
Put/Call ratio
-
1.01
-
Number of buys
-
118
-
Number of sells
-
-101
-
Price
-
$32.46
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2016
293 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q2 2016.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 110M shares
of 170M outstanding shares and own 64.92% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (24.5M shares), FMR LLC (17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.12M shares), VANGUARD GROUP INC (6.37M shares), OppenheimerFunds, Inc. (4.99M shares), Capital World Investors (3.76M shares), FRANKLIN RESOURCES INC (3.37M shares), JANUS CAPITAL MANAGEMENT LLC (3.2M shares), FRED ALGER MANAGEMENT INC (2.39M shares), and BlackRock Fund Advisors (2.34M shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.